Renal Denervation: New Evidence Supporting Long-Term Efficacy, Alternative Access Routes, and Cost-Effectiveness.
作者信息
Wang Tzung-Dau
机构信息
Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
Smart Health Technology Research and Development Center, National Taiwan University, Taipei City, Taiwan.
出版信息
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1528-1530. doi: 10.1111/jch.14945. Epub 2024 Nov 25.
Abstract
摘要
相似文献
1
Renal Denervation: New Evidence Supporting Long-Term Efficacy, Alternative Access Routes, and Cost-Effectiveness.肾去神经支配：支持长期疗效、替代入路及成本效益的新证据
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1528-1530. doi: 10.1111/jch.14945. Epub 2024 Nov 25.
2
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.基于导管的肾动脉去神经术治疗耐药性高血压的长期结果：随机 SYMPLICITY HTN-3 试验的最终随访。
Lancet. 2022 Oct 22;400(10361):1405-1416. doi: 10.1016/S0140-6736(22)01787-1. Epub 2022 Sep 18.
3
Effect of renal denervation on long-term outcomes in patients with resistant hypertension.肾去神经术对耐药性高血压患者长期结局的影响。
Cardiovasc Diabetol. 2021 Jun 5;20(1):117. doi: 10.1186/s12933-021-01309-3.
4
Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension.基于导管的肾动脉去神经术治疗耐药性高血压的成本效益和临床疗效。
J Am Coll Cardiol. 2012 Oct 2;60(14):1271-7. doi: 10.1016/j.jacc.2012.07.029. Epub 2012 Sep 12.
5
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.超声肾动脉去神经术治疗三联药物治疗抵抗的高血压（RADIANCE-HTN TRIO）：一项随机、多中心、单盲、假手术对照试验。
Lancet. 2021 Jun 26;397(10293):2476-2486. doi: 10.1016/S0140-6736(21)00788-1. Epub 2021 May 16.
6
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.在使用抗高血压药物的情况下肾动脉去神经术的长期疗效和安全性（SPYRAL HTN-ON MED）：一项随机、假手术对照试验。
Lancet. 2022 Apr 9;399(10333):1401-1410. doi: 10.1016/S0140-6736(22)00455-X. Epub 2022 Apr 4.
7
Renal denervation: unde venis et quo vadis?肾去神经支配：从何而来，去向何方？
Rofo. 2015 Apr;187(4):237-47. doi: 10.1055/s-0034-1385526. Epub 2015 Jan 28.
8
Ultra-long-term efficacy and safety of catheter-based renal denervation in resistant hypertension: 10-year follow-up outcomes.基于导管的肾去神经术治疗耐药性高血压的超长期疗效和安全性：10 年随访结果。
Clin Res Cardiol. 2024 Oct;113(10):1384-1392. doi: 10.1007/s00392-024-02417-2. Epub 2024 Mar 7.
9
Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Sweden.瑞典射频肾动脉去神经术治疗难治性高血压的成本效益分析。
Blood Press. 2025 Dec;34(1):2487583. doi: 10.1080/08037051.2025.2487583. Epub 2025 Apr 11.
10
Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Canada.加拿大射频肾动脉去神经术治疗难治性高血压的成本效益分析。
J Med Econ. 2025 Dec;28(1):70-80. doi: 10.1080/13696998.2024.2441072. Epub 2024 Dec 19.
本文引用的文献
1
Catheter-Based Renal Denervation for Resistant Arterial Hypertension: 10-Year Real-World Follow-Up Data.基于导管的肾去神经术治疗难治性动脉高血压：10年真实世界随访数据
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1521-1527. doi: 10.1111/jch.14931. Epub 2024 Nov 20.
2
Selecting Transfemoral Access or Upper Extremity Access for Renal Denervation Based on Vascular Morphology: Long-term Results.基于血管形态选择经股动脉入路或上肢入路进行肾去神经术：长期结果
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1513-1520. doi: 10.1111/jch.14937. Epub 2024 Nov 17.
3
Cost-Effectiveness of Radiofrequency Renal Denervation for Uncontrolled Hypertension in Japan.日本射频肾动脉去神经术治疗难治性高血压的成本效益分析
J Clin Hypertens (Greenwich). 2024 Dec;26(12):1502-1512. doi: 10.1111/jch.14922. Epub 2024 Nov 6.
4
The Netrod™ six-electrode radiofrequency renal denervation system for uncontrolled hypertension: a sham-controlled trial.用于治疗难治性高血压的Netrod™六电极射频肾去神经支配系统：一项假手术对照试验。
Eur Heart J. 2024 Nov 21;45(44):4761-4764. doi: 10.1093/eurheartj/ehae703.
5
Renal Denervation Lowers Nighttime Blood Pressure in True Resistant Hypertension.肾去神经支配可降低真性顽固性高血压患者的夜间血压。
Hypertension. 2024 Dec;81(12):e200-e202. doi: 10.1161/HYPERTENSIONAHA.124.23848. Epub 2024 Oct 21.
6
Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation in Chinese Patients With Uncontrolled Hypertension: The Randomized, Sham-Controlled, Multi-Center Iberis-HTN Trial.基于导管的射频肾去神经术治疗中国未控制高血压患者的疗效和安全性：随机、假对照、多中心 Iberis-HTN 试验。
Circulation. 2024 Nov 12;150(20):1588-1598. doi: 10.1161/CIRCULATIONAHA.124.069215. Epub 2024 Sep 4.
7
2024 ESC Guidelines for the management of elevated blood pressure and hypertension.2024年欧洲心脏病学会高血压管理指南
Eur Heart J. 2024 Oct 7;45(38):3912-4018. doi: 10.1093/eurheartj/ehae178.
8
SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations.SCAI关于高血压肾去神经支配的立场声明：患者选择、术者能力、培训与技术以及组织建议
J Soc Cardiovasc Angiogr Interv. 2023 Aug 21;2(6Part A):101121. doi: 10.1016/j.jscai.2023.101121. eCollection 2023 Nov-Dec.
9
Long-Term Blood Pressure Reductions Following Catheter-Based Renal Denervation: A Systematic Review and Meta-Analysis.基于导管的肾脏去神经支配后的长期血压降低：系统评价和荟萃分析。
Hypertension. 2024 Jun;81(6):e63-e70. doi: 10.1161/HYPERTENSIONAHA.123.22314. Epub 2024 Mar 20.
10
Catheters in vascular interventional radiology: an illustrated review.血管介入放射学中的导管：图文复习。
Diagn Interv Radiol. 2023 Jan 31;29(1):138-145. doi: 10.5152/dir.2022.21233. Epub 2022 Dec 28.
Zotero 插件